Stocktoria
Actinium Pharmaceuticals, Inc. ATNM
NYSE American · XASE · stock · Pharmaceutical Preparations · website · IPO 2014-03-26
Actinium Pharmaceuticals, Inc. statistics & valuation
Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -40274.4% | — | -64098.8% | -3311.1% | -2182.2% | — | — | — | — | — |
| Net margin | -37652.2% | — | -60269.1% | -3205.5% | -2165.6% | — | — | — | — | — |
| FCF margin | -27426.7% | — | -58627.2% | 803.7% | -1835.6% | — | — | — | — | — |
| Return on assets | -65.5% | -49.7% | -59.9% | -28.9% | -30.8% | -33.5% | -187.7% | -158.9% | -145.1% | -108.0% |
| Return on equity | -432.6% | -116.7% | -134.2% | -49.7% | -33.7% | -36.2% | -388.0% | -268.4% | -194.6% | -135.1% |
| Current ratio | 6.20 | 9.14 | 9.21 | 10.44 | 11.66 | 13.62 | 1.89 | 2.36 | 3.82 | 4.95 |
Source: SEC EDGAR filings · CIK 0001388320 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.